文献速递病毒性肝炎艾滋病与性传播感染

澳大利亚HIV阳性男男性行为者能否在2025年达到WHO丙肝消除目标?

Can Australia Reach the World Health Organization Hepatitis C Elimination Goal by 2025 Among Human Immunodeficiency Virus-positive Gay and Bisexual Men?
PubMed 文献 · Clin Infect Dis · 2020-01-01

研究用丙肝传播模型预测澳大利亚HIV阳性男男性行为者至2025年的丙肝发病率变化。若直接抗病毒药物使用比例维持每年65%且高危行为不变,发病率将从2016年2.5/100人年降至0.4/100人年(下降85%),可实现WHO消除目标。

要点

  • 维持每年65%的DAA使用率且行为不变,2025年丙肝发病率可降85%
  • 风险行为大幅增加时,发病率降幅仍可达76%
  • DAA使用率降至每年20%且行为不变,发病率仅降70%

核心结论

  • 澳大利亚HIV阳性男男性行为者到2025年达到WHO丙肝消除目标是可行的。

研究设计与样本

  • 使用丙肝传播模型,以澳大利亚数据参数化,预测至2025年治疗和行为变化对HIV阳性男男性行为者丙肝发病率的影响。

主要发现

  • 模型丙肝发病率从2000年0.7/100人年升至2016年2.5/100人年,与既往临床数据轨迹一致。
  • DAA使用比例每年65%且高危性行为和注射吸毒维持当前水平时,发病率降至0.4/100人年(较2016年下降85%)。
  • 同一治疗情景但风险行为大幅增加时,发病率降至0.6/100人年(下降76%)。
  • DAA使用比例从2016年每年65%降至2025年每年20%且风险行为不变时,发病率降至0.7/100人年(下降70%)。

临床怎么用

  • 维持较高的DAA治疗覆盖(如每年65%)对实现丙肝消除目标至关重要。
  • 需同步关注高危性行为和注射吸毒等风险行为的变化对发病率的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Human immunodeficiency virus (HIV)-positive gay and bisexual men (GBM) in Australia are well engaged in care. The World Health Organization's (WHO) hepatitis C virus (HCV) elimination target of an 80% reduction in incidence by 2030 may be reachable ahead of time in this population. METHODS: We predicted the effect of treatment and behavioral changes on HCV incidence among HIV-positive GBM up to 2025 using a HCV transmission model parameterized with Australian data. We assessed the impact of changes in behavior that facilitate HCV transmission in the context of different rates of direct-acting antiviral (DAA) use. RESULTS: HCV incidence in our model increased from 0.7 per 100 person-years in 2000 to 2.5 per 100 person-years in 2016 and had the same trajectory as previously reported clinical data. If the proportion of eligible (HCV RNA positive) patients using DAAs stays at 65% per year between 2016 and 2025, with high-risk sexual behavior and injecting drug use remaining at current levels, HCV incidence would drop to 0.4 per 100 person-years (85% decline from 2016). In the same treatment scenario but with substantial increases in risk behavior, HCV incidence would drop to 0.6 per 100 person-years (76% decline). If the proportion of eligible patients using DAAs dropped from 65% per year in 2016 to 20% per year in 2025 and risk behavior did not change, HCV incidence would drop to 0.7 per 100 person-years (70% reduction). CONCLUSIONS: Reaching the WHO HCV elimination target by 2025 among HIV-positive GBM in Australia is achievable.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Boettiger DC, Salazar-Vizcaya L, Dore GJ, et al. Can Australia Reach the World Health Organization Hepatitis C Elimination Goal by 2025 Among Human Immunodeficiency Virus-positive Gay and Bisexual Men? Clin Infect Dis. 2020. PMID: 30816916. doi:10.1093/cid/ciz164

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。